When the Food and Drug Administration approves a new treatment or vaccine, as doctors we are assured that rigorous studies have proven it to be safe and effective. But the F.D.A.â€™s haphazard issuance of emergency use authorizations for Covid-19 treatments like hydroxychloroquine and convalescent plasma, whose potential benefits have not yet been backed up by data, has undermined this trust. 
